Continuous treatment with baricitinib is needed to maintain hair regrowth in patients with severe alopecia areata.

Patients with alopecia areata found effective treatment with baricitinib, which had long-term efficacy and positive results.

NEW ORLEANS — Patients who responded to baricitinib treatment for alopecia areata continued to maintain those results with long-term treatment, according to a speaker at the American Academy ...

After 1 year’s worth of hair regrowth among patients treated with baricitinib for severe alopecia areata, treatment withdrawal resulted in a loss of benefit for almost all patients ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

In an interview with Brittany Craiglow, MD, FAAD, dermatologist at Dermatology Physicians of Connecticut in Fairfield, she advocates for combination therapies using baricitinib to treat pediatric ...

Last year, the U.S. Food and Drug Administration approved the use of the JAK inhibitor baricitinib to treat severe alopecia areata — but only in adults. King, who was the lead investigator in that ...

Additionally, long-term data from two randomized trials of the JAK inhibitor baricitinib (Olumiant) in alopecia areata showed durable effects, as 90% of patients who met response criteria at 52 ...

Highlights: First systemic medication has been approved by the FDA for severe alopecia areata The medication is called baricitinib, a previous arthritis drug shows promising results for cure of ...

Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about ...

3.18 The clinical experts considered baricitinib to be a step-change in managing severe alopecia areata for which there are limited licensed treatment options. In response to the draft guideline ...